Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients

被引:52
作者
Shaikh, S
Collier, DA
Sham, P
Pilowsky, L
Sharma, T
Lin, LK
Crocq, MA
Gill, M
Kerwin, R
机构
[1] TAIPEI CITY PSYCHIAT CTR,TAIPEI,TAIWAN
[2] FORENAP CTR HOSP,ROUFFACH,FRANCE
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1995年 / 60卷 / 06期
关键词
allelic association; neuroleptics; quantitative trait; tandem repeat;
D O I
10.1002/ajmg.1320600611
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have examined the hypothesis that a variable number of tandem repeats in the third cytoplasmic loop of the dopamine D4 receptor influences clinical response to clozapine using a sample of 189 schizophrenic patients, Alleles of the 48-bp repeat, which range from two to ten copies in the normal human population, were analysed by the polymerase chain reaction using genomic DNA as template, Association between these alleles and response to clozapine was tested using the difference in pre- and post-treatment GAS scores as a measure of response. We found no statistically significant variation between genotypic groups and response by analysis of variance. We conclude that the variation of the number of 48-bp repeats alone does not determine response to clozapine, Larger studies are underway to determine if there is a more subtle relationship with sequence variation within the repeats or at other polymorphic sites within the gene that may provide evidence for a component of clozapine's action being at D4 receptors. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:541 / 545
页数:5
相关论文
共 28 条
[1]   ASSOCIATION BETWEEN CLOZAPINE RESPONSE AND ALLELIC VARIATION IN 5HT(2A) RECEPTOR GENE [J].
ARRANZ, M ;
COLLIER, D ;
SODHI, M ;
BALL, D ;
ROBERTS, G ;
PRICE, J ;
SHAM, P ;
KERWIN, R .
LANCET, 1995, 346 (8970) :281-282
[2]  
BELMAKER RH, 1981, CLIN GENET, V19, P353
[3]   DISTRIBUTION OF A NOVEL MUTATION IN THE 1ST EXON OF THE HUMAN DOPAMINE-D(4) RECEPTOR GENE IN PSYCHOTIC-PATIENTS [J].
CATALANO, M ;
NOBILE, M ;
NOVELLI, E ;
NOTHEN, MM ;
SMERALDI, E .
BIOLOGICAL PSYCHIATRY, 1993, 34 (07) :459-464
[4]  
COLE JO, 1966, PSYCHIATRIC DRUGS, P153
[5]  
COWARD DM, 1989, PSYCHOPHARMACOLOGY, V99, P86
[6]   THE NORTHWICK PARK STUDY OF 1ST EPISODES OF SCHIZOPHRENIA .2. A RANDOMIZED CONTROLLED TRIAL OF PROPHYLACTIC NEUROLEPTIC TREATMENT [J].
CROW, TJ ;
MACMILLAN, JF ;
JOHNSON, AL ;
JOHNSTONE, EC .
BRITISH JOURNAL OF PSYCHIATRY, 1986, 148 :120-127
[7]   PROBLEMS IN CLASSIFICATION OF SCHIZOPHRENICS AS NEUROLEPTIC RESPONDERS AND NONRESPONDERS [J].
CSERNANSKY, JG ;
KAPLAN, J ;
HOLLISTER, LE .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1985, 173 (06) :325-331
[8]   DISPOSITION OF CLOZAPINE IN MAN - LACK OF ASSOCIATION WITH DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS [J].
DAHL, ML ;
LLERENA, A ;
BONDESSON, U ;
LINDSTROM, L ;
BERTILSSON, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (01) :71-74
[9]  
FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538
[10]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789